SpringWorks Therapeutics, Inc.
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that…
Biotechnology
US, Stamford [HQ]
SWTX/Financial Reporting
Income Statements
Profit & Loss · 6 Statements · From 2023 to 2018Configuration
In Million USD. Margins, Growth Rates In %
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Revenue | - - | - - | 35.00 | - - | 6.00 | 5.00 | |
|
EPS
|
-0.80 | -1.27 | -1.02 | -3.57 | -5.14 | -5.15 | |
| Diluted in mil. | -0.80 | -1.27 | -1.02 | -3.57 | -5.14 | -5.15 | |
|
Profit
|
- - | - - | 34.00 | - - | 4.00 | 5.00 | |
| Gross Margin | - - | - - | 99.00 | - - | 69.16 | 92.25 | |
| Pre Tax | -17.00 | -58.00 | -45.00 | -173.00 | -277.00 | -325.00 | |
| Profit Margin | - - | - - | -130.21 | - - | -4,513.05 | -5,968.50 | |
| ETR | -3.81 | 6.08 | 2.92 | 0.40 | 1.17 | 7.06 | |
| Net | -17.00 | -54.00 | -44.00 | -173.00 | -274.00 | -325.00 | |
| Profit Margin | - - | - - | -126.41 | - - | -4,460.06 | -5,968.50 | |
| EBITDA | -18.00 | -59.00 | -45.00 | -172.00 | -280.00 | -341.00 | |
| EBITDA Margin | - - | - - | -131.36 | - - | -4,566.03 | -6,266.68 | |
| Operating Income | -18.00 | -59.00 | -46.00 | -173.00 | -280.00 | -343.00 | |
| Operating Margin | - - | - - | -132.35 | - - | -4,566.03 | -6,297.28 | |
| Interest Income | - - | 3.00 | 1.00 | - - | 6.00 | 22.00 | |
| Loss | -18.00 | -59.00 | -81.00 | -173.00 | -280.00 | -348.00 | |
| Cost of Revenue | - - | - - | - - | - - | -1.00 | - - | |
|
Operating Expenses
|
-18.00 | -59.00 | -81.00 | -173.00 | -280.00 | -348.00 | |
| R&D | -9.00 | -42.00 | -51.00 | -101.00 | -146.00 | -150.00 | |
| G&A | -8.00 | -16.00 | -29.00 | -71.00 | -134.00 | -197.00 | |
| SG&A | -8.00 | -16.00 | -29.00 | -71.00 | -134.00 | -197.00 | |
| S&M | - - | - - | - - | - - | - - | - - | |
| Depreciation and Amortization | - - | - - | - - | - - | - - | -1.00 | |
| Interest Expenses | - - | - - | - - | - - | - - | - - | |
| Other Expenses | - - | - - | - - | - - | -3.00 | -5.00 | |
|
WA Shares Outstanding
|
22.00 | 43.00 | 43.00 | 48.00 | 53.00 | 63.00 | |
| Diluted | 22.00 | 43.00 | 43.00 | 48.00 | 53.00 | 63.00 |